Consequently, the cGAS-STING pathway assumes a complex and critical role in lung cancer progression and immune evasion, necessitating further investigation to fully elucidate its therapeutic potential and address the challenges associated with targeting it for lung cancer therapy. This evidence concerns the gene STING1 and lung carcinoma.